Skip to content

Study Details

Dual-Tracer Theranostic Position Emission Tomography (PET)

(IRB#: IRB_00158172)

Position Emission Tomography (PET) /CT scans are a way to see images inside of the body. Theranostics are a combination of using a radioactive drug to diagnose and a second radioactive drug to deliver therapy. Research is needed to develop methods that combine 2 different types of scans. These may be given to patients with neuroendocrine tumors and prostate cancer. The goal of the study is to eliminate the need to have the scans given separately and combine them into one patient health clinic visit.


  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 18 years and older
  • Presence of at least 1 measurable lesion
  • Diagnosis of prostate or neuroendocrine cancer
  • Willing to lie flat on your back for up to one hour for data imaging
  • Willing to have two separate PET/CT exams on different days within two weeks of each other

Exclusion Criteria

  • Previously participated in any therapeutic clinical study
  • Known allergic or hypersensitivity reactions to radioactive drugs used for imagining
  • Too claustrophobic to have PET/CT scanning
  • Pregnant or currently breast feeding

Will I be paid for my time?


For more information contact:

Regan Butterfield


IRB#: IRB_00158172

PI: Jeffrey Yap


Approval Date: 2022-10-20 06:00:00

Study Categories: Cancer Studies, Prostate Cancer Studies

Specialties: Radiology

Last Updated: 6/8/23